Based on this multiparametric analysis, a high frequency of activated (CD38+) TPH was found associated with the disease activity in a limited number of AIH patients, suggesting its potential use as a biomarker in clinical practice16. This evidence concerns the gene TPH1 and autoimmune hepatitis.